Page last updated: 2024-11-01

ofloxacin and Central Pontine Myelinolysis

ofloxacin has been researched along with Central Pontine Myelinolysis in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
" Renal-dose levofloxacin was utilized as part of an antimicrobial regimen to treat post-operative peritonitis."3.74Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia. ( Gregory, J; Huesmann, G; Jakoby, MG; Vallurupalli, S, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vallurupalli, S1
Huesmann, G1
Gregory, J1
Jakoby, MG1

Other Studies

1 other study available for ofloxacin and Central Pontine Myelinolysis

ArticleYear
Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia.
    Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:7

    Topics: Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemia; Kidne

2008